Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Ciclosporin/eltrombopag

Venous embolic cerebral infarction

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Hong Y, et al. Synergistic Effect of Low-Dose Cyclosporine a on Eltrombopag (EPAG) in the Management of Prior Epag and Multiline Failed Immune Thrombocytopenia Patients: A Single-Center, Self-Control Study. Blood 140 (Suppl. 1) : 8386-8387, Nov 2022. Available from: URL: https://dx.doi.org/10.1182/blood-2022-159032 [abstract] Hong Y, et al. Synergistic Effect of Low-Dose Cyclosporine a on Eltrombopag (EPAG) in the Management of Prior Epag and Multiline Failed Immune Thrombocytopenia Patients: A Single-Center, Self-Control Study. Blood 140 (Suppl. 1) : 8386-8387, Nov 2022. Available from: URL: https://​dx.​doi.​org/​10.​1182/​blood-2022-159032 [abstract]
Metadaten
Titel
Ciclosporin/eltrombopag
Venous embolic cerebral infarction
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56085-0

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Tetanus-vaccine

Case report

Antineoplastics